Jacob Thomas, MD
Ophthalmology · Springfield, MONPI 1538328489
Payments from drug & device makers
Across 135 payments — averaging $46.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$2K
- AbbVie$1K
- Alcon$674
- Regeneron Healthcare Solutions, Inc.$639
- Genentech USA, Inc.$290
- Rxsight Inc$250
- plus $1K from 12 others
What the payments were for
- Travel & lodging$1,79329%
- Food & beverage$4,32570%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 7 | $2,128 |
| AbbVie(2 entities) | 41 | $1,203 |
| Alcon | 33 | $674 |
| Regeneron Healthcare Solutions, Inc. | 9 | $639 |
| Genentech USA, Inc. | 11 | $290 |
| Rxsight Inc | 3 | $250 |
| Glaukos Corporation | 2 | $240 |
| Bausch & Lomb Americas Inc. | 9 | $212 |
| Sun Pharmaceutical Industries Inc. | 6 | $148 |
| Aerie Pharmaceuticals, Inc. | 2 | $122 |
| Nova Eye, Inc. | 1 | $107 |
| Novartis | 5 | $79 |
| Kala Pharmaceuticals, Inc. | 1 | $25 |
| Oyster Point Pharma, Inc. | 1 | $24 |
| Harrow Eye, LLC | 1 | $23 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Ivantis, Inc | 1 | $15 |
| Sight Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$2,063
- Tecnis 3-piece IOL$2,063
- Tecnis Symfony IOL$2,063
- Tecnis Symfony Toric IOL$2,063
- EYLEA HD$249
- DURYSTA$238
- BOTOX$190
- RXSIGHT CONTACT LENS$131
- RXSIGHT INJECTOR CARTRIDGE$131
- RXSIGHT INJECTOR HANDPIECE$131
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$131
- LIGHT ADJUSTABLE LENS (LAL)$131
- Skyrizi$124
- iStent Infinite$123
- iDoseTR$123
- AcrySof$120
- OZURDEX$119
- iDose$117
- IC-8 Apthera IOL$106
- Rhopressa$103
How this compares
$6,211 in reported general payments places this provider in the 75th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 50 | $50,695 |
| Prednisolone Acetate | 887 | $22,588 |
| LumiganBimatoprost | 37 | $18,675 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 90 | $14,445 |
| RhopressaNetarsudil Mesylate | 23 | $12,850 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 44 | $12,690 |
| CombiganBrimonidine Tartrate/Timolol | 40 | $11,875 |
| ValacyclovirValacyclovir Hcl | 198 | $11,116 |
| Cyclosporine | 15 | $8,260 |
| Latanoprost | 853 | $6,352 |
| RocklatanNetarsudil Mesylat/Latanoprost | 12 | $3,982 |
| Alphagan PBrimonidine Tartrate | 19 | $3,889 |
| Timolol Maleate | 450 | $3,603 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 446 | $3,515 |
| Travoprost | 34 | $3,458 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $1,203 | $85,134146 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $122 | $16,83235 claims |
| AlconSimbrinza | $674 | $12,69044 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $20 | $2,01611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 286 ophthalmology providers in Missouri.
Other ophthalmology in Springfield
- Shachar TauberSpringfield$265K
- Wendell ScottSpringfield$142K
- Thomas PraterSpringfield$30K
- Nancy HolekampChesterfield$2.7M
- Steven SilversteinKansas City$1.6M
- Joseph TauberKansas City$1.3M
- Steven CouchSaint Louis$1.2M
- Andrew MoyesKansas City$1.1M
- Ranjan MalhotraSaint Louis$964K
- Navin TekwaniSaint Louis$957K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.